Komodo Health & Partners Present 33 Real-World Evidence Research Studies at ISPOR 2024 [Yahoo! Finance]
NeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
NeoGenomics, Inc. (NASDAQ: NEO) had its price target lowered by analysts at BTIG Research from $23.00 to $21.00. They now have a "buy" rating on the stock.
NeoGenomics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
NeoGenomics, Inc. (NASDAQ: NEO) had its price target lowered by analysts at TD Cowen from $21.00 to $20.00. They now have a "buy" rating on the stock.